| PUBCHEM ID |
44152971
|
| UNII |
OIH1H7CJCJ
|
| Preferred Term |
PADOPORFIN
|
| CAS |
274679-00-4
|
| INCHIKEY |
GPIVNYFDHQDTDZ-GDUCSYRESA-L
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CC[C@@H](/[C@@H]1C)C(/C=C(/C(C)=C2C([C@H]3C(OC)=O)=O)\NC2=C3C([C@H](CCC(O)=O)/[C@H]2C)=N/C2=C2)=N/C1=C\c1c(C(C)=O)c(C)c2[nH]1
|
| Total Surface Area |
449,65
|
| Relative PSA |
0,27517
|
| TPSA |
150,28
|
| cLogS |
-6,623
|
| MW |
610,709
|
| cLogP |
3,4785
|
| H-Acceptors |
10
|
| H-Donors |
3
|
| Ro5 violations |
1
|
| Druglikeness |
-4,3389
|
| DrugScore |
9,74234264410569E-02
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
high
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,4954
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
0,978
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,6302
|
| Tetrahymena Pyriformis Toxicity |
High HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,6117
|
| Carcinogenicity (Three-class) |
Non-required
|